← FDA DRUG APPROVALS

FDA ANDA · ANDA075284

KETOROLAC TROMETHAMINE

Sponsor: PLIVA

APPLICATION
ANDA075284
TYPE
ANDA
ORIGINAL APPROVAL
1999-06-23
LATEST ACTION
2016-05-09
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

KETOROLAC TROMETHAMINEDiscontinued
KETOROLAC TROMETHAMINE 10MG · TABLET · ORAL

Approval history

2016-05-09Labeling · Supplement 11 · standardAP
2007-02-06Labeling · Supplement 6AP
2005-04-12Labeling · Supplement 5AP
2000-07-07Manufacturing (CMC) · Supplement 1AP
1999-06-23OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →